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Abstract. 
The development of good quality and affordable ultrasound machines has led to the establishment and 
implementation of numerous point-of-care ultrasound (POCUS) protocols in various medical disciplines. POCUS 
for major infectious diseases endemic in tropical regions has received less attention, despite its likely even more 
pronounced benefit for populations with limited access to imaging infrastructure. Focused assessment with 
sonography for HIV-associated TB (FASH) and echinococcosis (FASE) are the only two POCUS protocols for 
tropical infectious diseases, which have been formally investigated and which have been implemented in routine 
patient care today. This review collates the available evidence for FASH and FASE, and discusses sonographic 
experiences reported for urinary and intestinal schistosomiasis, lymphatic filariasis, viral hemorrhagic fevers, 
amebic liver abscess, and visceral leishmaniasis. Potential POCUS protocols are suggested and technical as well as 
training aspects in the context of resource-limited settings are reviewed. Using the focused approach for tropical 
infectious diseases will make ultrasound diagnosis available to patients who would otherwise have very limited or 
no access to medical imaging. 
INTRODUCTION 
Ultrasound (US) has been used to aid diagnosis and to guide therapy in a large number of 
tropical infectious diseases for a long time.
1
 During the past two decades, technological advances 
have improved image quality and significantly reduced the size and price of US equipment. As a 
result, US has been established as a point-of-care test in clinical decision making and for 
procedural guidance in various medical specialties.
2
 Point-of-care ultrasound (POCUS) is one of 
the few novel diagnostic tools to which the criticism of inflationary use of the term point-of-care 
does not apply.
3
 Emergency medicine (EM) physicians have pioneered and greatly advanced the 
point-of-care application of US. Today, the “focused assessment with sonography for trauma” 
(FAST) protocol is not only well recognized as a standardized diagnostic test in emergency 
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departments, but also constitutes an integral part of diagnostic algorithms and EM training.
4–7
 
The fundamental difference between POCUS and conventional US examination is that POCUS 
is performed by the treating physician who aims to answer simple, usually binary questions 
relevant to immediate patient management (e.g., “Is there a pleural effusion, yes or no?”). 
POCUS is not a comprehensive US assessment.
8
 Diagnoses for which POCUS is suitable should 
fulfill two criteria: 1) diagnosis must be relevant to consecutive treatment decision making and 2) 
diagnosis must be easily and accurately recognizable by physicians applying US without the 
necessity for extended US training. Although patients’ benefit from POCUS in affluent settings 
is mainly a reduced time to diagnosis and further management, POCUS in resource-constrained 
settings provides the additional benefit that it is frequently the only diagnostic imaging modality 
available.
9,10
 
This review first describes the development and application of “focused assessment with 
sonography for human immunodeficiency virus (HIV)–associated tuberculosis (TB)” (FASH),11–
16
 which is the most widely studied and implemented application of POCUS in infectious 
diseases to date. Subsequently, other infectious diseases, endemic in tropical or resource-limited 
settings and accounting for significant morbidity and mortality in affected populations and for 
which POCUS has been investigated or for which POCUS may be a potential diagnostic tool, are 
reviewed and discussed. In view of the required focused approach of POCUS, it is important not 
only to define diagnostic criteria and test accuracy for each disease, but also to identify the target 
population in which the diseases of interest are highly prevalent and for whom POCUS will 
therefore be valid and most beneficial (e.g., HIV/TB coinfection in South Africa, echinococcosis 
in rural Argentina, or the Kenyan Turkana region). Finally, technical and teaching considerations 
are discussed. 
FOCUSED ASSESSMENT WITH SONOGRAPHY FOR HIV/TB 
TB is one of the most frequent opportunistic infections in HIV patients living in tropical 
countries and constitutes an immense problem in sub-Saharan Africa and beyond.
17
 
Extrapulmonary TB (EPTB) is seen more frequently in immunocompromised patients and is 
more difficult to diagnose than pulmonary TB. Disseminated TB is a major cause of death in 
patients with HIV.
18
 Clinical symptoms are fever, weight loss, and night sweats, possibly with 
cough, shortness of breath, or other focal symptoms; frequently, cardinal signs and symptoms are 
less clearly evident in HIV coinfected individuals. 
The diagnosis of EPTB in HIV-infected patients is challenging but vital to patient 
management. The majority of EPTB patients in resource-poor settings are diagnosed on the basis 
of clinical case definitions (e.g., World Health Organization [WHO]
19
) and only in a minority of 
cases is microbiological confirmation feasible. The value of US for diagnosing EPTB has long 
been recognized. The sonographic features suggestive of EPTB, in populations with a high 
prevalence of HIV/TB coinfection, are as follows: 
 
1. Pleural effusion, particularly when unilateral. In a study from sub-Saharan Africa, unilateral pleural effusion was 
caused by TB in over 90% of cases and was highly associated with HIV infection.
20
 
2. Pericardial effusion is consistently reported to be due to TB and to be associated with HIV coinfection in the 
majority of cases in Africa.
21
 Pericardial fluid can easily be identified by POCUS,
22
 as well as its hemodynamic 
significance and potential need for pericardiocentesis.
23
 
3. Although not included in current WHO guidelines, enlarged abdominal lymph nodes and splenic microabscesses 
have been repeatedly reported as characteristic findings of abdominal TB in HIV-infected patients (Figure 1A).
24
 
Lymph nodes affected by TB present as hypoechoic round structures and are considered pathological when larger 
than 1.5–2 cm. Abdominal tuberculous lymphadenopathy is frequently located in the upper abdomen, for example, 
in the liver hilum, around the celiac axis and in the para-aortic area. In some cases, lymphadenopathy can also be 
found in the mesentery of the caecum (especially in cases of cecal involvement of TB) and in the splenic hilum. 
Splenic microabscesses are visible as multiple hypoechoic lesions between 0.5 and 1 cm, in an often enlarged spleen 
(Figure 1B). Presence of ascites can also be a sign of peritoneal TB, especially, if further features suggestive of 
abdominal TB are demonstrated. 
The feasibility and success of training clinicians to accurately detect abdominal 
lymphadenopathy and splenic microabscesses through short courses, using a curriculum 
developed in South Africa, has been demonstrated.
25
 It has also been documented extensively in 
EM that pleural,
26
 pericardial,
27
 and ascitic
4
 fluid can be detected by POCUS with high 
sensitivity and specificity. There is no reason to doubt the similar value of POCUS for the 
detection of effusions and ascites secondary to infectious diseases. As a logical consequence, a 
single POCUS protocol for EPTB (FASH) has been compiled using the US views of FAST and 
US views for detection of abdominal lymphadenopathy and splenic microabscesses
11
 (Figure 2). 
Because of the high prevalence of HIV/TB coinfection, FASH has become one of the most 
frequently used POCUS modules in South Africa.
15
 Further studies showed that in approximately 
25% of patients with a FASH examination suggesting EPTB, the patient’s chest X-ray was not 
suggestive of TB, indicating a significant proportion of patients in whom the diagnosis will be 
missed if only chest X-ray is performed as part of their diagnostic TB work-up.
13
 The use of 
FASH in pediatric patients is currently under investigation, but preliminary data indicate that 
FASH is also applicable in the pediatric population.
16
 An evaluation of FASH as a tool to 
monitor response to treatment in HIV-infected patients with EPTB showed that the persistence of 
positive findings, after a treatment period of 3 months, is an indicator of treatment complications 
such as mycobacterial resistance, poor compliance, or immune reconstitution inflammatory 
syndrome.
14
 It needs to be emphasized that a definitive diagnosis of the etiology underlying 
FASH findings is not possible by US only; however, in a high-prevalence setting, commencing 
TB treatment based on clinical and sonographic findings and observing the patient’s clinical and 
sonographic response is justified.
28
 
FOCUSED ASSESSMENT WITH SONOGRAPHY FOR ECHINOCOCCOSIS 
Cystic echinococcosis (CE) is highly prevalent in sheep farming areas, especially in central 
Asia, China, South America, the Mediterranean, eastern Europe, and considerable parts of 
Africa.
29,30
 In humans, CE cysts develop predominantly in the liver (60–70%) and lungs (20–
30%). On average, 60–75% of infected patients with hepatic CE are asymptomatic.31 When 
present, symptoms may be local (most commonly right upper quadrant pain) or systemic (fever, 
jaundice, or allergic manifestations), due to mass effect, communication with hollow structures, 
superinfection, or loss of integrity of the cyst’s wall. Based on individual case reports, it has been 
hypothesized that HIV may affect the course of CE and lead to unusual and potentially more 
severe clinical disease.
32
 
US is the technique of choice for abdominal CE diagnosis, staging, and follow-up
33
 and 
enables US-assisted percutaneous therapeutic procedures. The different types of cysts can be 
grouped according to the WHO-IWGE (Informal Working Group on Echinococcosis) 
classification, which is also the basis of the stage-specific approach to the clinical management 
of CE (Figure 3).
34,35
 
Sonographic features of CE cysts are as follows
35
: 
1. Double wall of the cyst, especially evident in fluid-filled CE1 cysts. 
2. “Water lily sign” of CE3a cysts, which reflects the detached endocyst fluctuating in the cyst fluid content. 
3. “Honeycomb appearance” of multivesiculated cysts (CE2 and CE3b), in which the impression of “septa” is 
formed by the adjacent walls of daughter vesicles (CE2) or in which daughter vesicles have formed in pseudo-solid, 
hyperechoic, and nonhomogeneous cyst content (CE3b). 
4. The “ball-of-wool” sign of CE4 cysts, characterized by the appearance of hypoechoic, degenerating cyst 
membranes folded inside pseudo-solid cyst content. 
5. The wall calcification of cysts with pseudo-solid content (CE5). 
Key in the differentiation between CE1 and simple cysts is the visualization of the double 
wall, which is absent in nonparasitic cysts. Serology and, if necessary, US-guided aspiration and 
microscopic analysis of the cyst content will further aid the diagnosis. 
US screening for hepatic CE has been conducted in many endemic countries for years.
36–40
 
For example, in Argentina, a yearly 2-day “focused assessment with sonography for 
echinococcosis” (FASE) training course has been implemented since 2000, where general 
practitioners working in rural endemic areas with no previous experience with US are trained in 
FASE. Four standard images are acquired, and according to results of scans and consultations 
with experts, patients are offered stage-specific clinical management.
36
 Annual screening of large 
populations and regular long-term follow-up of diagnosed cases without costly travel by the 
patients to tertiary care facilities, as well as reduction in loss to follow-up, were achieved. The 
repeated annual training ensures sustainability, by compensating for the high turnover of general 
practitioners in rural areas. 
In other endemic settings, the implementation of short protocols allowing the diagnosis and 
classification of CE cysts according to the WHO-IWGE criteria could provide the basis for early 
detection and clinical management of the infection. As cysts of different stages show very 
different responses to various management options,
41–44
 staging supported through remote advice 
by experts in treatment centers could be helpful. 
OTHER INFECTIOUS DISEASES WITH POTENTIAL FOR POCUS APPLICATION 
Amebic liver abscess. 
Amebiasis is one of the most common parasitic diseases worldwide and is prevalent in all 
tropical countries.
45
 Amebic liver abscess is more common in adults than in children and more 
common in men than in women. Patients usually present with fever, possibly right upper 
quadrant pain and jaundice. The condition is well suited for a POCUS approach.
46
 
Sonographically, amebic liver abscess presents as a focal hepatic lesion, which is single in 
60% of cases and is most commonly located in the posterior part of the right lobe (Figure 4A). 
The abscess is usually hypoechoic compared with normal liver tissue, without an appreciable rim 
or capsule. In the center or at the periphery of the abscess, hyperechoic areas may be seen. After 
anti-amebic treatment,
47
 the lesion tends to become more hypoechoic and the margins become 
better defined.
48,49
 Serology can support the diagnosis when available; US-guided aspiration 
shows material of necrotic hepatocytes (“anchovy sauce“) typical in amoebic abscesses. 
Diagnosis does usually not require aspiration. The clinical and sonographic picture, in 
conjunction with a history of possible exposure, is sufficient to start metronidazole treatment. 
Today, the indication for aspiration as diagnostic or therapeutic intervention is mainly limited to 
cases with an acute risk of rupture.
50
 
The main clinical and sonographic differential diagnosis of amebic liver abscess is pyogenic 
liver abscess (Figure 4B). These are more commonly reported outside the tropics, often in 
patients with risk factors, such as biliary tree infections, diverticulitis, and a history of abdominal 
intervention. Although occasionally difficult to identify in the early stages, because of similar 
echogenicity of the surrounding liver tissue, pyogenic lesions eventually become hypoechoic 
compared with liver and can be more variable in shape and often have irregular walls. Pyogenic 
liver abscesses are also more often multiple, involving both lobes of the liver, and some show 
areas of marked echogenicity due to gas bubbles, which are not a feature of amoebic abscesses 
unless superinfected. Treatment can be attempted with broad-spectrum antibiotics covering 
gram-negative and anaerobic bacteria. 
A few further etiologic infectious differentials of abscess-like liver lesions need to be 
mentioned. If a central calcification is visible within the abscess, Brucella infection should be 
considered.
51
 Fasciola infection may present with hypoechoic lesions, especially subcapsular, 
and forming linear “tracks” through the liver.52 As with hepatic CE, other differential diagnoses 
of focal liver lesions, infectious and noninfectious, need to be considered. 
Apart from individual case descriptions,
46
 no published data on the use of POCUS to 
diagnose amoebic and other liver abscesses is available. POCUS protocols to screen the liver 
using 3–4 scan positions, including an intercostal and epigastric approach appear feasible, but 
will need validation in further studies. Upon finding a characteristic lesion, antibiotic treatment 
may be started. However, if a liver lesion does not show the typical, characteristic appearances of 
an abscess or CE cyst for example, and the binary approach of POCUS cannot be applied, the 
findings should be viewed with caution and treatment decision should be guided by clinical 
assessment. Referral for a formal US assessment or other imaging, where available, should also 
be considered. 
Schistosomiasis. 
Schistosomiasis is a waterborne helminthic infection mainly affecting either the urogenital 
tract (Schistosoma haematobium) or the gastrointestinal tract (Schistosoma mansoni, 
Schistosoma japonicum). To a lesser extent, all can affect the lung causing pulmonary 
hypertension.
53
 More than 250 million people are affected worldwide and there are more than 
200,000 deaths per year attributable to schistosomiasis in sub-Saharan Africa.
54
 
Schistosomiasis-associated morbidity is due to inflammation and consecutive fibrosis around 
entrapped eggs in the tissues. This leads to progressive organ damage and failure.
53
 It is 
important to note that morbidity persists even after eggs are no longer detectable in stool or 
urine. This highlights the importance of early antihelminthic therapy to prevent and reverse early 
fibrosis.
55
 
Urogenital schistosomiasis. 
Urogenital infection is seen mainly in sub-Saharan Africa, Egypt, and on the Arabian 
Peninsula. Schistosoma haematobium adult worms mature in the vesical plexus. The hallmark 
symptoms of urogenital schistosomiasis are dysuria and hematuria; earlier symptoms, 
particularly in children, include fatigue and anemia.
56
 The peak of morbidity is observed in 
children aged 7–14 years; however, infection occurs as early as infancy in endemic areas.57 In 
longstanding infections, symptoms of urinary tract obstruction and kidney failure are seen, 
secondary to fibrosis of bladder and ureter. Squamous cell carcinoma of the bladder is a possible 
late complication. 
Fibrotic changes of the urinary tract because of schistosomiasis can easily be identified by 
US,
58
 and findings are described in WHO guidelines for identification and reporting of 
schistosomiasis.
59
 Bladder wall thickening and intravesical masses are common observations; in 
advanced disease, upper urinary tract obstruction is characterized by dilatation of the renal pelvis 
(Figure 5). 
US in urinary schistosomiasis has been reported to be an “simple-to-learn” examination.60 In 
support of this assertion, the detection of urinary tract dilatation (e.g., as a consequence of 
urolithiasis) is commonly taught in POCUS courses in EM for the evaluation of flank pain. A 
POCUS protocol for urinary schistosomiasis using the lateral abdominal scans to visualize the 
kidneys, and a pelvic scan for the bladder could be developed and studied for clinical feasibility 
and value. As schistosomiasis has a highly focal geographical distribution, it is important to 
identify endemic areas and patient groups at risk. In former hyperendemic regions, where control 
programs have reduced the prevalence of infection, patients with low-intensity infection and 
sequelae may still be found. Diagnosis may be missed if it is only based on the detection of eggs 
in urine, as the egg excretion does not necessarily correlate with egg entrapment. Patients with 
urogenital schistosomiasis could therefore be identified by suggestive POCUS and then treated 
with praziquantel. Most bladder pathology regresses after treatment and can be monitored by US. 
Urinary tract dilatation frequently persists even in successfully treated patients.
61
 Non-resolving 
masses, especially in adult patients, should be investigated further by cystoscopy in view of the 
risk of bladder cancer. 
Intestinal schistosomiasis. 
Although the highest prevalence of S. mansoni infection leading to intestinal and 
hepatosplenic disease is found in sub-Saharan Africa, cases are also encountered in the 
Caribbean and South America, mostly Brazil. Schistosoma japonicum, affecting similar organs, 
remains endemic in limited areas of China, the Philippines, and parts of Indonesia.
62
 As S. 
mansoni adult worms mature in the portal vein, schistosomiasis-associated morbidity develops as 
eggs become entrapped in the tissues (bowel wall and periportal area) causing initial 
inflammation and subsequent fibrosis. Liver changes evolve from mild to severe periportal 
fibrotic changes with preservation of parenchyma until the final stages. Reactive splenic 
hyperplasia and portal hypertension ensue and dire downstream consequences include death 
from bleeding of esophageal varices.
63
 
The diagnostic sonographic liver features, such as echogenic rings or streaks around the 
portal venous branches and echogenic bands extending from the main portal vein to the liver 
surface, are well described; various fibrosis patterns are summarized in a WHO report (Figure 
6).
59
 In S. japonicum infections, the additional finding of a network of fibrosis may be seen, 
resulting in a so-called “tortoise back” appearance.59 The WHO patterns are well established and 
widely used.
64
 
Focused US in intestinal schistosomiasis could be used for different purposes depending on 
the stage of the disease: 1) identifying early, potentially reversible fibrotic changes (WHO 
patterns B–D) in patients (mostly children) from endemic areas, who would benefit from medical 
treatment with antiparasitic treatment (praziquantel) and 2) identifying affected patients at 
imminent risk of bleeding (WHO patterns E and F), who might benefit from endoscopy. 
WHO patterns B–D, representing patients with mild liver fibrosis, are not pathognomonic 
and can be difficult to differentiate from normal liver or other disease etiologies.
65
 The 
interobserver agreement has been found to be low, especially for mild cases.
66
 Without the US 
imaging experience needed to subcategorize these patients accurately, misdiagnosis of milder 
cases of intestinal schistosomiasis can easily occur. Patients with image pattern B and C rarely 
need endoscopy as their risk of bleeding is low. However, in endemic areas, those patients could 
benefit from early treatment that potentially slows down the development of ongoing, and 
reverses early fibrosis. 
US can reliably visualize significant hepatic fibrosis (WHO patterns E and F), which is 
helpful in identifying patients with clinically advanced disease. These patients are at higher risk 
of variceal bleeding
67
 and should undergo endoscopy if possible. The patient’s risk for variceal 
bleeding increases when portal hypertension is present. Sonographic changes suggestive of portal 
hypertension are an increased diameter of the portal vein (normally < 12 mm in adults) or splenic 
vein (normally < 9 mm),
68
 the presence of ascites, and the development of portosystemic 
collateral vessels.
59
 The most commonly described collateral veins are the perigastric, the 
paraumbilical, and the splenorenal veins. Detection is increased by color Doppler, which also 
allows detection of hepatofugal circulation.
68
 Enlargement of the caudate lobe compared with the 
right lobe is another finding, which is relatively easy to visualize by US, and reflects changes in 
portal blood supply in the cirrhotic liver. Caudate lobe enlargement has been described in 
patients with schistosomiasis.
69
 Splenomegaly can also be a sign of portal hypertension, and in 
schistosomiasis, the spleen may show multiple nonspecific tiny echogenic foci (Gamna–Gandy 
bodies).
70
 The size of the spleen is easy to assess; however, possible alternative diagnoses such 
as chronic splenomegaly in areas hyperendemic for malaria, visceral leishmaniasis (VL), or 
chronic HIV infection reduce its entity-specific diagnostic value in the absence of collaterals. 
When signs of portal hypertension are present, patients should undergo endoscopy whenever 
possible even if they only show milder forms of periportal fibrosis (pattern D). 
For busy clinicians, the entire WHO protocol, including multiple measurements, might be too 
complicated and time consuming. A simplified POCUS protocol applying a few standardized 
liver views could be devised to identify patients with hepatosplenic involvement in intestinal 
schistosomiasis and to identify in particular those patients at risk of variceal bleeding. The results 
would guide management decisions: antihelminthic treatment
47
 and sonographic follow-up for 
mild cases and antihelminthic treatment and referral to a tertiary center with capacity to perform 
endoscopic sclerotherapy for severe cases. 
LYMPHATIC FILARIASIS 
Lymphatic filariasis, predominantly caused by Wuchereria bancrofti, is a disfiguring and 
disabling disease affecting an estimated 120 million people throughout the tropics. The highest 
burden of pathology is born by infected men showing hydrocele; another sign is lower limb 
lymphedema. 
US has proven particularly useful in detecting pathology in male patients. So far, it has 
mainly been used to detect moving worms in supratesticular lymphatic vessels of infected men 
participating in clinical trials (the so-called “filarial dance sign”). Worm nest finding in women 
may also be possible, although less frequently documented.
71
 Large volume hydrocele in males, 
hyperechoic appearance of scrotal fluid, and presence of lymph scrotum (thickened scrotal skin > 
0.45 cm, porous and wart like, pain attacks, and leakage of lymph fluid) are associated with 
increased risk of testicular inflammation and necrosis (Figure 7).
72
 Recently, it has been reported 
that 56% of examined males in an endemic area in Ghana presented with hydroceles of variable 
degree and 9% showed echodense fluid,
73
 suggesting a considerable proportion of patients to be 
at risk of testicular inflammation and necrosis; the relative frequency of different “filaricele” 
conditions is, however, unknown. 
The use of POCUS approach beyond clinical trials for management of individual patients has 
received much less attention. Brief US protocols scanning the scrotum for abovementioned signs 
could be useful in allocating patients with hydrocele to high- or low-risk groups and to adapt the 
therapeutic approach. Medical treatment with doxycycline ameliorates lymphedema and 
hydrocele in infected patients (i.e., with detectable filarial circulating antigens).
74,75
 Interestingly, 
doxycycline treatment has also been found to ameliorate mild to moderate lymphedema in 
patients without active infection (i.e., filarial antigen negative),
76
 but so far it is unknown if this 
treatment is also effective in early stages of hydrocele in patients without active infection. 
Surgical programs for hydrocele due to lymphatic filariasis have been launched,
77
 and it is 
crucial to identify patients at high risk of scrotal complications for referral to surgery. POCUS 
could play a decisive role in this identification. 
VISCERAL LEISHMANIASIS 
Each year, an estimated 500,000 new patients suffer from VL caused by many different 
species of Leishmania; the disease burden is particularly high on the Indian subcontinent and in 
east Africa.
78
 Patients present with fever, cough, abdominal pain, diarrhea, wasting, and 
pancytopenia. US consistently reveals hepatosplenomegaly, and, in a large proportion of cases, 
abdominal lymphadenopathy.
79,80
 In recent reports, nodular changes in the spleen have been 
reported, particularly in children
81
 but also in adults.
82
 
Whether these US findings, which could be incorporated into a POCUS protocol, could help 
with the diagnosis or follow-up of VL and/or with the differential diagnosis between TB and VL 
in coendemic areas, remains to be studied. The hardest-hit regions (southern Sudan; Bihar State, 
India) would be locations where such POCUS protocols could be of value and where studies of 
the validity of such POCUS protocols could be conducted. 
VIRAL HEMORRHAGIC FEVER 
Viral hemorrhagic fevers (VHFs) are caused by a variety of viruses (Arenaviridae, 
Filoviridae, Bunyaviridae, Flaviviridae, and Rhabdoviridae). Worldwide, dengue virus is the 
most common VHF, but in specific geographic areas other viruses such as Crimean–Congo 
hemorrhagic fever (CCHF) virus may be also prevalent. Because of the large-scale outbreak in 
west Africa in 2014 and its high mortality rate,
83
 the Ebola virus has recently gained much 
importance. Clinically, VHF infections present with fever, headache and muscle pain, rashes, 
and abdominal symptoms. On progression, hemorrhagic phenomena such as thrombocytopenia, 
bruises, and internal bleeding occur, which may be followed by shock and death. 
US detection of effusions (pleural, pericardial, and ascitic) have been described as signs of 
plasma leakage in children
84
 and adults
85
 with dengue infection. The presence of effusions 
correlated with progression to more severe forms of the disease (dengue hemorrhagic fever 
(DHF), dengue shock syndrome), and its negative predictive value was found to be very high.
85
 
Gallbladder wall thickening
85,86
 and subcapsular splenic and hepatic fluid collections
87
 have also 
been reported as signs of plasma leakage. It has been suggested that during a dengue epidemic, 
the diagnosis of DHF should be considered when US demonstrates gallbladder wall thickening, 
ascites, splenomegaly, and pleural effusion in a febrile patient with thrombocytopenia.
88
 
Similarly, in a multivariate analysis in CCHF, gallbladder wall thickening, and intra-
abdominal fluid collections were found to be significantly associated with disease severity.
89,90
 
Validation of a standardized POCUS protocol to diagnose and predict severity of VHF in 
epidemic situations and to adapt monitoring and supportive treatment accordingly appears 
worthwhile. 
Beside the potential predictive value for severity assessment in VHF, US can be used to 
determine hemodynamic parameters in patients with VHF. POCUS is well established in the care 
of critically ill patients for the assessment of the filling status of the inferior vena cava and the 
left ventricle.
91
 Intercostal scanning of the lung can show suggestive signs of interstitial 
pulmonary edema, and thus guide fluid administration.
92
 This is particularly helpful in patients 
with highly contagious VHF as other forms of physical examination such as auscultation may be 
hindered by isolation measures and protective equipment. A preliminary report on the use of US 
in patients infected with Ebola virus supports these indications and suggests the use of focused 
POCUS done by infectious disease clinicians trained in isolation measures and in relevant 
POCUS protocols.
93
 Small mobile US equipment should remain in the isolation unit to prevent 
spread of the infection. 
MISCELLANEOUS INFECTIOUS DISEASES 
The potential value of US in supporting diagnosis and management of a range of other 
infectious diseases in tropical areas and beyond appears huge and increasing. Varying experience 
with US for assessment of infectious diseases has been reported and some are mentioned in brief 
below. The suitability and value of POCUS protocols in these diseases remains to be studied. 
Diagnostic usefulness of US in infections caused by flukes other than Schistosoma spp. has been 
reported for fascioliasis-related hepatic and biliary disease,
52,94,95
 pulmonary and abdominal 
paragonimiasis,
96
 and clonorchiasis.
97
 Other helminthic infections for which US has been used 
include onchocerciasis,
98–100
 abdominal and ocular toxocariasis,
101,102
 and ascariasis and its 
complications such as bile duct invasion.
103–105
 Further parasitic diseases for which experimental 
US experience is available include Chagas disease,
106
 myiasis,
106,107
 and even malaria.
108
 The 
usefulness of POCUS in bacterial infectious diseases has recently been reviewed, describing 
differentiation between cellulitis and abscesses, diagnosis of septic arthritis, identifying 
underlying causes of sepsis, and pneumonia.
109
 Further US applications have been reported for 
leprosy,
110,111
 rheumatic heart disease as sequelae of Streptococcus pyogenes infection,
112
 
mycetoma,
105
 and opportunistic infections in patients living with HIV.
113,114
 With US getting 
closer to the point of care and into the hands of treating physicians, its use in infectious diseases 
may increase, and further POCUS indications may become established. 
TECHNICAL AND TRAINING REQUIREMENTS 
Technical. 
Technical requirements for POCUS equipment are relatively basic. Most commercially 
available machines can be used. 
The size of the device plays an important role when mobile scanning is intended. 
The availability of electricity and US gel needs to be considered in remote settings, and a voltage stabilizer may be 
required in a situation where voltage peaks put the machine at risk of damage. 
In many places, only gray-scale (“black and white”) scanners will be available, which can perfectly serve the 
purpose. The additional availability of color Doppler on the scanner is helpful to identify blood flow. It will, for 
example, be helpful to find collaterals in abdominal schistosomiasis, but also be of value in identifying vessels in 
other anatomical regions. It does, however, significantly increase the cost of the equipment. 
To facilitate web-based, remote review and support, an option to extract digital images and video clips onto an 
external storage device is highly desirable. 
The final choice of equipment will mainly depend on local availability and maintenance provision. Obviously, the 
available budget plays a substantial role, but cost of equipment has come down significantly in recent years, 
improving affordability. 
Training. 
US is a highly operator-dependent tool, which can easily lead to misdiagnosis if implemented 
inappropriately and without adequate training. The WHO scientific Group on Clinical Diagnostic 
Imaging concluded that “… more important than the equipment is the availability of skills….”115 
For comprehensive US use, the WHO recommends that physicians should undergo training over 
3–6 months, including 300–500 examinations. However, these formal training programs, while 
ideal, are often too time consuming to achieve meaningful coverage in resource-limited settings. 
In the absence of formally trained sonographers or radiologists, US training should be aimed at 
health-care professionals, especially those working on the front line. In particular, this means 
general physicians and clinical officers in district hospitals and clinics who have little or no 
experience with imaging technology and who cannot afford to be away from their clinical duties 
for a long training course. Focused POCUS applications do not require as much training, and 
thus allow a degree of flexibility. If physicians could be trained in short courses, which will 
reduce their absence from clinical duties, while providing them with the most relevant US 
skills,
10
 this would widen access to this very useful diagnostic modality. 
Short courses have been reported to be sufficient to teach POCUS modules.
116
 Regular, short 
US courses with a focus on infectious diseases are held in Pavia, Italy,
117
 in Lima, Peru,
118
 and 
previously in Liverpool, United Kingdom.
119
 
However, the great advantage of courses held directly in low-resource settings is that they 
will allow local physicians to participate without excessive travel expenses or lengthy leave of 
absence. In addition, this allows for more rapid and relevant learning, as infection-specific 
pathologic findings are more prevalent in endemic areas. Short training courses have been 
reported from various sites in resource-limited settings.
9,120–122
 However, there has been neither 
widespread dissemination nor standardization of these training initiatives nor robust validation, 
particularly in terms of the operator’s maintenance of adequate technical ability in the long term. 
In addition, there is no literature available on how many exams are needed to achieve 
competency in US skills for clinicians in developing countries. However, in industrialized 
countries, figures of approximately 30–40 supervised examinations are consistently reported in 
the literature to master one particular POCUS protocol. For example, 40 exams are reportedly 
necessary to accurately detect intrauterine first trimester pregnancy and complications,
123
 while 
only 30 may be needed to learn how to detect hydronephrosis.
124
 As it has become apparent that 
some operators acquire skills more rapidly than others, there is an increasing move toward 
uniform, cross-specialty competency-based assessment, which may be of benefit when designing 
future courses.
125
 
As external trainers are often only available for short periods, other methods to ensure 
continuous support and quality assurance need to be considered. With increasing availability of 
Internet access and faster connections in geographically remote settings, the application of 
telemedicine solutions could be expanded to support practitioners in areas where direct 
supervision is scarce or absent. Recently, the feasibility of a tele-US system using Skype

 and 
cheap, widely available, consumer electronics equipment, was successfully piloted for remote 
supervision of FASH exams in Lambaréné, Gabon.
12
 Another, even easier, option is the 
extraction of digital images and video clips that can then be sent via secure telemedicine servers 
for review and second opinion. 
A number of introductory texts covering the use of US in infectious diseases exist.
126–128
 All 
are specifically aimed at physicians with limited imaging experience working in resource-limited 
settings and are available free or at low cost. 
Several associations such as the American College of Emergency Physicians
129
 endorse the 
approach of focused US exams. A section of the International Federation for Emergency 
Medicine has recently developed a consensus document drawing on regional and national 
guideline standards and training requirements to summarize recommendations for an appropriate 
level of training that will allow for the provision of a safe and effective US service.
130
 Analogous 
to these recommendations, the development of standardized training and practice guidelines for 
POCUS courses in the field of infectious diseases, based on previous experience and available 
training material, is a key priority in the field. Recommendations and standards, building on 
those existing for EM US, should be created. In our opinion, a modular approach consisting of 
theoretical and practical sessions would be feasible. Initially, protocols and questions, which are 
easier to master, such as FASH or the detection of urinary tract changes in schistosomiasis can 
be taught. Once the trainee gains experience in the technology of US, technically more 
demanding topics such as liver POCUS, echinococcal cyst morphology, and even the assessment 
of collateral vessels may be taught in further modules. A rigorous evaluation of these training 
methods is highly desired, but unfortunately not yet available. Modular training could facilitate 
the availability and accelerate the spread of POCUS. 
CONCLUSIONS 
US is a powerful diagnostic tool, which has become increasingly available and affordable. 
From the aforementioned considerations and our own clinical experience, we are of the opinion 
that POCUS is ideally suited to the diagnosis of several infectious conditions in resource-limited 
settings. We believe that focused, high-quality training will be the key to the successful 
expansion of US applications. To facilitate this, standardized protocols and training curricula that 
enable health-care workers to answer dedicated, “focused” questions need to be developed and 
validated in the field. Using the focused approach will make US diagnosis available to patients 
who would otherwise have very limited or no access to medical imaging. 
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FIGURE 1. (A) Epigastric transverse view: enlarged round hypoechoic tuberculous lymph nodes (arrows) behind the 
liver in the area of the celiac trunk. (B) Left longitudinal flank view: enlarged spleen with small hypoechoic lesions 
(arrow) due to tuberculous microabscesses. 
 
FIGURE 2. Ultrasound (US) probe positions used in focused assessment with sonography for human 
immunodeficiency virus–associated tuberculosis (FASH) protocol. (A) Epigastric/subxiphoidal transverse view, (B) 
longitudinal pleural view right, (C) longitudinal right flank/upper quadrant view, (D) longitudinal pleural view left, 
(E) longitudinal left flank/upper quadrant view, and (F) transverse pelvic view. 
 
FIGURE 3. Suggested cystic echinococcosis (CE) stage-specific clinical management options according to World 
Health Organization Informal Working Group on Echinococcosis (WHO-IWGE) Expert consensus.
34
 PAIR = 
puncture, aspiration, injection of a scolicidal agent, and re-aspiration. Non-PAIR percutaneous treatments include 
several percutaneous techniques using cutting instruments and large bore catheters to evacuate the entire cyst 
content. 
 
FIGURE 4. (A) Right longitudinal upper quadrant view: amebic liver abscess posteriorly in the right lobe of the liver, 
presenting as a round hypoechoic lesion with hyperechoic debris and without a clearly discernable wall. (B) Right 
longitudinal upper quadrant view: pyogenic liver abscess presenting as an irregularly shaped, hypo- to anechoic 
lesion, containing hyperechoic gas bubbles with posterior acoustic shadowing. 
 
FIGURE 5. (A) Longitudinal pelvic view: thickened and irregular wall of the urinary bladder secondary to 
Schistosoma haematobium infection. (B) Right longitudinal flank view: dilatation of the renal collecting system, 
secondary to fibrosis and obstruction in S. haematobium infection. 
 
FIGURE 6. Epigastric transverse view: liver with bright hyperechoic fibrosis surrounding the intrahepatic portal 
vessels, due to Schistosoma mansoni. 
 
FIGURE 7. (A) Longitudinal scan of hemiscrotum showing anechoic fluid hydrocele. (B) Longitudinal scan of 
hemiscrotum showing low-intensity echoes in hydrocele fluid and thickened scrotal skin. 
 
TABLE 1 
Summary of reported experiences of POCU assessment of tropical infectious diseases 
Disease (protocol) Population Clinical symptoms US findings Suggested action Evidence Reference 
TB (FASH) Africa (particularly 
southern Africa), 
Asia, and South 
America with high 
HIV/TB 
coinfection 
prevalence 
Fever Enlarged hypoechoic lymph nodes Do sputum smear exam Well described 
and widely used 
in South Africa 
11–15,127
 
Weight loss Micro-abscesses in spleen and/or liver Start empirical TB 
treatment 
Cough Pleural effusion Test for HIV if not done 
previously and treat 
accordingly 
Abdominal symptoms 
(diarrhea, pain, and 
abdominal distension), 
shortness of breath 
Pericardial effusion 
Hypotension Ascites 
Echinococcosis (FASE) Sheep farming 
populations, South 
America, Middle 
East, eastern 
Europe, The 
Mediterranean, 
Central Asia, 
China, east Africa 
Symptoms depend on 
cyst’s size, number, and 
organ affected 
Appearance depends on cyst stage (WHO-
IWGE) 
Stage-specific treatment of 
liver CE (WHO-IWGE) 
FASE 
implemented in 
Argentina 
33–36,40,43
 
Jaundice CE1: anechoic with double wall 
Right upper quadrant pain CE2: honeycomb appearance, adjacent 
anechoic daughter vesicles contained in the 
“mother” cyst’s wall 
Most cases have few or no 
symptoms 
CE3a: anechoic with “lily sign” (detached 
endocyst) 
CE3b: daughter vesicles within a solid 
matrix of the “mother” cyst 
CE4: inhomogeneous content with visible 
hypoechoic folded endocyst (“ball of 
wool” sign) 
CE5: same as CE4 with calcified wall 
Amebic liver abscess Worldwide in 
tropical countries 
Fever Hypoechoic, but not anechoic, round 
homogenous liver lesion => amebic 
abscess? 
Start antibiotic e.g., 
metronidazole treatment 
Individual 
descriptive studies 
only 
46,48,49
 
Right upper quadrant 
abdominal pain 
Differentials: Amebic serology 
a) Lesion containing gas, irregular shape 
=> pyogenic abscess? 
In imminent rupture, US-
guided aspiration 
b) Central calcification => abscess due to 
brucellosis? 
Brucella serology 
c) Noninfectious lesion, e.g., necrotic 
tumor 
Intestinal schistosomiasis People in contact 
with fresh water in 
Africa, southeast 
Asia, and Brazil 
Abdominal pain Increasingly wide echogenic fibrosis 
around portal tracts (pattern D–F) 
Refer for endoscopy for 
patterns E + F 
WHO guidelines 
available for 
population 
screening 
59,64–70
 
Intestinal bleeding “Tortoise back” pattern in Asia Refer also if pattern D and 
signs of portal 
hypertension 
Malabsorption Dilated portal and splenic vein and 
collateral vessels 
Treat medically and advise 
against exposure for other 
cases Hepatosplenomegaly Enlarged caudate lobe 
Fever Splenomegaly 
Eosinophilia Ascites 
Malnutrition, anemia 
Urogenital 
schistosomiasis 
People in contact 
with fresh water in 
Egypt and sub-
Saharan Africa 
Hematuria Irregular, thickened bladder wall (in fully 
distended bladder) 
Medical treatment WHO guidelines 
available for 
population 
screening 
58–60
 
Urinary tract symptoms Upper urinary tract dilation Possibly referral for 
cystoscopy in case of 
persistence 
Fever Bladder polyps and masses 
Eosinophilia 
Malnutrition, anemia 
Dyspareunia 
Gastrointestinal bleeding 
Infertility 
VHFs (e.g., dengue, 
CCHF, Ebola) 
Widely prevalent 
throughout the 
tropics 
Fever Effusions (pericardial, pleural) and ascites 
as signs of plasma leakage 
Intensified surveillance for 
patients with negative 
prognostic signs 
Individual 
descriptive studies 
only 
84–87,89,90,93
 
Muscle pain Gall bladder wall thickening Changes in fluid 
replacement therapy in 
shock 
Headache Subcapsular hepatic fluid Consider vast differential 
diagnoses Rash Volume status assessment (IVC, left 
ventricle, and pulmonary edema) Petechia 
Lymphatic filariasis Sub-Saharan 
Africa, southeast 
Asia, and endemic 
areas of Central 
and South America 
Hydrocele Dilation of inguinal lymphatic vessels Scrotal surgery for 
hyperechoic, complex 
hydrocele 
Individual 
descriptive studies 
only 
71,73
 
Lower limb lymphedema Filarial dance sign Conservative treatment 
with doxycycline and 
deferred surgery for echo-
free hydrocele 
Echo-free or hyperechoic hydrocele 
Thickened scrotal skin 
 
 
VL Indian 
subcontinent, 
Sudan 
Fever Hepatosplenomegaly Unclear Individual 
descriptive studies 
only 
79,80
 
Abdominal pain Lymph node enlargement 
Pancytopenia Nodular splenic lesions (diagnostic 
accuracy of these findings is currently 
unclear for diagnosis of visceral 
leishmaniasis) 
CCHF = Crimean–Congo hemorrhagic fever; CE = cystic echinococcosis; FASE = focused assessment with sonography for echinococcosis; FASH = focused 
assessment with sonography for HIV-associated TB; HIV = human immunodeficiency virus; IVC = inferior vena cava; POCU = point-of-care ultrasound; TB = 
tuberculosis; US = ultrasound; VHFs = viral hemorrhagic fever; VL = visceral leishmaniasis; WHO-IWGE = World Health Organization Informal Working 
Group on Echinococcosis. 
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